Working Groups

EUCROF encourages the initiatives of its Members to form Working Groups (WGs), which represent an open area of discussion on specific areas of interest for Members. Any (Associate) Member can contribute to the WGs by nominating a representative. The WGs meet regularly through TCs and/or face to face meetings. In accordance to the focus of each WG, they are intended to become counterpart/stakeholders for Regulatory Authorities, Industry, Academia and Patients' Associations, write papers in Scientific Journals, actively participate to Congresses/Conferences, thus representing the position and the interests of EUCROF. 

Chair

Antoinette VAN DIJK
Switzerland
Phone: +41 79 51 17 359
Mobile: +39 335 56083680
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 

 

Members

WG Chair: Antoinette van Dijk

WG Members – Vivienne van de Walle (PT&R - The Netherlands), Ornela Cullufe (CVBF - Albania), Claudine Richon (Ennov - France), Şebnem Yaşaroğulları (MENE Research - Turkey), Mahak Aneja (Emovis - Germany), Olga Baula (ULC - Ukraine).

 

FLYER - Clinical Trials Centres WG rev

Chair

Dagmar CHASE
BVMA
Phone: +49 89 92 92 87 0
Fax: +49 89 92 92 87 50
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

The EUCROF Clinical Trials Legislation Working Group (CTL WG) is aimed to represent European CROs when input is sought from stakeholders by legislators (e.g., EMA, EU Commission) or international organisations (e.g., ICH, WHO) in the context of new provisions for clinical trials. It is crucial that CROs provide their perspectives and opinions as more than 60% of clinical trials are handled by CROs. The delegation of sponsor duties and functions to CROs is important to be taken into account when legal regulations and guidance documents are developed. EUCROF does not miss this chance and continuously participates in the consultation rounds offered by legislators and/or international organisations.

The CTL WG is in operation since more than a decade and has given input to numerous documents with latest activities on the “Management of Clinical Trials under COVID-19 Pandemic”.

It is our mission to effectively use the voice we have through the European CRO Federation.

We are looking forward to continue our active involvement in the development of Clinical Trials documents.

 

Members

WG Chair: Dagmar Chase

WG Members – Ulrike Lorch (Richmond Pharmacology - UK), Emma Akuffo (Richmond Pharmacology - UK), Maria Moumouri (Next CRO - Greece), Catherine Ferre (PRA Health Sciences - France), Catalina Sarbu (Parexel - Romania), Mihaela David (PSI CRO - Romania), Cristina Manfredi (CVBF - Italy), Vladimir Vujović (Optimapharm - Serbia), Ivan Vyshnyvetskyy (ULC - Ukraine), Cari Joacobs-Blom (CR2O - The Netherlands), Tineke de Boer (Pra Health Science - The Netherlands), Angela Hougardy (proDERM - Germany).

 

FLYER - Clinical Trial Legislation WG rev

Chair

Christophe GOLENVAUX
BeCRO
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Members

WG Chair – Christophe Golenvaux

 

WG Members – Darina Hrdličková (ACRO-CZ - Czech Republic), Simon Lee (CCRA - UK), Véronique Marty (AFCROs - France), Mariangela Lupo (CVBF - Italy), Michael Shumilin (ULC - Ukraine), Assia Rosati (EUCROF).

Chair

Harry Therianos

Medical Director - Coronis Research S.A. (Athens, Greece)

Tel.: (+30)210.87.78.000

email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Members

WG Chair – Harry Therianos

WG Members – Maria Kyrana (Coronis Research - Greece), Phil Evans (CCRA/Quotient Sciences - UK), Nand Sing (CCRA/Quotient Sciences - UK), Yves Donazzolo (Eurofins Optimed - France), Maria Bernardo (PPD - Spain),  Caridad Fernandez (PPD – Spain), Nadia Zeini (Premier Research - Spain), Emma Akuffo (Richmond Pharmacology - UK), Ralph Freese (CTC North, Germany), Annik van Riel (SGS - Belgium).

Chair

Donato BONIFAZI
Chief Executive Officer - Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF, Italy)

Tel.: +39 080 975 1974
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

WG Chair – Donato Bonifazi

Reema Alhwij (CVBF - Italy), Harsha Basudev (Parexel - Italy), Simone Bucerius (FGK Clinical Research - Germany), Ana Dilo Bala (CVBF - Albania), Anamaria Dzoja Horvat (Optimapharm - Croatia), Cristina Florescu Moriad (AVANTYO - Romania), Manika Kreka (CVBF – Albania), Marieke Meulemans (GCP Central - The Netherlands), Ana Moreno (Apices - Spain), Ana Stoiković (Optimapharm D.O.O. - Croatia), Katerina Tsagaraki (Coronis Research - Greece), Goran Vesov (Optimapharm D.O.O. - Croatia).

 

ET WG Flyer rev

Chair

Dolores Pérez Méndez

Sermes CRO, Spain

Phone: +34 608 505 507

 Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Members

WG Chair – Dolores Pérez Méndez

WG Members – Stefan Siegmund (Convidia - Germany), Rasid Kamal (PPD - Czech Republic), Lari Forrester (IQVIA - The Netherlands).

 

Mission of WG

The goal of this WG is to identify, examine and provide solutions to the principal issues identified in Advanced Therapy Medical Products development and regulation, in constant dialogue and collaboration with the Industry and European Authorities.

 

Main objectives

  • Profiling of EUCROF towards the ATMPs Authorities in EU.
  • Profiling of EUCROF towards the Advanced Therapies industry.
  • Propose solutions to improve the application and assessment process related to ATMPs.

 

Meetings

Meeting by teleconference (Monthly/ every two months)

WG Chair - Şebnem Yaşaroğulları

Vice President Clinical Operations

email: This email address is being protected from spambots. You need JavaScript enabled to view it.

MENE Health Group
Phone. +90(262) 678 88 67 - Fax. +90(262) 751 28 38 - Cell. +90(533) 740 84 63
www.menehealthgroup.com 

Members

WG Chair – Şebnem Yaşaroğulları

WG Members – Antoinette van Dijk (D.O. Research - Switzerland), Karen Gabriels (Archer Research - Belgium), Sofoklis Kyriazakos (Innovation Sprint - Belgium), Antonio Pitarque(Sermes CRO - Spain), Rob Schneijdenberg (Syneos Health - The Netherlands), Mieke Tempels (Archer Research - Belgium), Rianne Tooten (Acron - The Netherlands)

 

FLYER - Medical Devices WG rev

Chair

Alan Yeomans

Quality Manager 

PCG Solutions AB 

Mobile : +46 70 540 0299 

This email address is being protected from spambots. You need JavaScript enabled to view it. 

Co-Chair 

Yoani Matsakis 

President 

TELEMEDICINE TECHNOLOGIES S.A.S. 

Mobile: +33 6 85 04 57 21

This email address is being protected from spambots. You need JavaScript enabled to view it. 

The group evaluates new technologies that impact the clinical trial environment and evaluates how these can benefit clinical research.

 

Goals

  • Keep EUCROF Members informed on directions in New Technology
  • Technology survey: how much technology can improve clinical trials
  • Position EUCROF as an expert / key stakeholder for the EU regulatory bodies

Members

WG Chair – Alan Yeomans

WG Co-chair – Yoani Matsakis

WG Initiator – Yoani Matsakis

WG Members – Thierry Lepoutre (Lambdaplus – Belgium), Vasiliki Mani (Excelya - Greece), Sofoklis Kyriazakos (Alcoam By Design - France), Fiona Maini (Medidata Solutions - UK), Eva Hanzlova (Scope International - Czech Republic), [Mika Lindroos, Finland - eCF].

 

Meetings

Webinar meetings are approximately once a month (about 10 times a year).

Face-to-face meetings can be held in conjunction with EUCROF conferences if there is a need.

 

Distribution of Information

  • EUCROF conferences
  • White papers distributed through the EUCROF website
  • Looking into the use of webinars
    • Can be open to members or non-members
    • Can be paying or non-paying webinars
  • Looking into the use of social media
    • EUCROF have an active LinkedIn group which can be used for appropriate information

 

FLYER - New Technology WG rev

Chair

Dr Martine DEHLINGER-KREMER
ICON Plc (Germany)
Phone: +49 1738966437
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Members

WG Chair – Dr Martine Dehlinger-Kremer

WG Members – Alex Cvetkovic Muntañola (Syneos Health – Spain), Sofia Romboli (Excelya -  Greece), Jürgen Schäfer (Conreso GmbH – Germany), Donato Bonifazi (CVBF – Italy), Nira Garty (Perfection-CRO Ltd – Israel), Pavla Nevolova (EastHORN - Czech Republic), Ian Vasicka (Co-Investigator/Advisor - Czech Republic), Nuria Martinez-Alier (IQVIA/Advisor – UK).

 

EUCROF PWG Flyer (16 February 2022)

 

Chair

Marta Manso

This email address is being protected from spambots. You need JavaScript enabled to view it.

Business Development

SERMES CRO

 

 

Goals

Fostering actual & confident collaboration with patients in clinical research.

 

  1. Contribute to promote and disseminate best practices of collaboration with patients’ associations involved in study design, run and patient retention in clinical studies.
  2. Ease the effort of CROs having need to involve patients in national and/or international projects.
  3. Ensure involvement of EUCROF as a stakeholder providing consolidated CRO perspectives about the operational collaboration with patients in clinical research. 
  4. Contribute to the recognition by authorities, industry and patients’ advocacy groups of best practices of collaboration with patients in clinical studies and access to innovation.
  5. Create and maintain an annual observatory of patient-centricity experiences and patients associations’ expectations about clinical studies across European countries.

 

Members

WG Members – Marta Manso (Spain), Mariangela Lupo (Italy), Simon Klaasen (The Netherlands), Manika Face Kreka (Albania), Ornela Cullufe (Albania), Hélène Moussu (France), Miriam Cabrita (Belgium), Annick Daems (Belgium), Joan Escudero (Spain), Helen Green (UK), Fanny Rossignon (The Netherlands), David Blanco (Spain), Karen McIntyre (UK), Karen Bailey (UK), Sue Fitzpatrick (UK).

 

Meetings

Webinar meetings on a monthly base.

Face-to-face meetings.

 

Distribution of Information

  • EUCROF conferences
  • Social media
  • White papers
  • Position papers
  • Publications in journals
  • Scientific conferences
  • Cross communication with patients’ advocacy groups
  • EUCROF website

 

FLYER - Patients Association WG rev

Chair

Nicolas TSIAKKAS
Scientific Director
Medwork Pharma Research & Consulting
5, Chiou st., 164 52 Argyroupoli, Athens, Greece
Phone: +30 210 9960971
Fax: +30 210 9969578

 

 

Co-Chair

Xavier FOURNIE, M.D.

Scientific Medical Affairs Consulting

Hospital Practitioner*

Mobile: +33 (0)6 08 65 71 12

4 Chemin du Plain Vallon, 69300 CALUIRE ET CUIRE , FRANCE

*HCL- Hôpital Pierre Garraud, SSR/iVie, 136 rue Commandant Charcot, 69005 LYON, FRANCE.

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 

Goals

Position EUCROF PV WG as important conduit and as a reference for stakeholders in the EU pharmacovigilance fora

Main objectives:

  • Cooperation with other EUCROF Working Groups
  • Pro-active Interaction with the Agency
  • Affiliation with relevant stakeholder groups
  • Sharing PV expertise within the EUCROF
  • PV Knowledgebase Build-up and Dissemination

 

Members

 

WG Chair – Nicolas Tsiakkas

WG Co-chair – Xavier Fournie

WG Members – Marco Anelli (Productlife-group – Italy), Zurab Koberidze (FGK-PV – Germany), Fleming Kjær Jørgensen (Klifo – Denmark).

 

FLYER - PharmacoVigilance WG rev

 

Chair

Alexandre Malouvier

Senior Director Commercial & Strategic Healthcare & Technology Partnerships

Dir Tel: +33 (0)1 41 34 45 59  

Mobile: + 33 (0)6 14 34 72 31

email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Members

WG Chair: Alexandre Malouvier

   

WG Co-chair: Denis Comet (Axonal - France)

WG Members: Sarah Beeby (consultant - UK), Liliana Cunha (Clinical Trial & Consulting - Portugal), Remi Gauchon (ICTA - France), Rhian Kiely (Open Health - UK), Sonja Kroep (Pharmerit - The Netherlands), Sofoklis Kyriazakos (Innovation Sprint - Belgium),  Klairi Liakou (Zeincro - Greece), Berk Özdemir (Omega - Turkey), Dana Perotti (Castor - The Netherlands), Nawab Qizilbash (OXON Epidemiology - UK), Giuseppe Recchia (daVinci Digital Therapeutics - Italy), Berber Snoeijer (ClinLine - The Netherlands), Dana Vankova (IQVIA - Czech Republic), Ophélie Wilczynski (Carenity - France).

 

Meetings

Monthly meeting is generally organized through teleconference

 

FLYER - Real World Data and Digital Health WG rev